These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32522210)

  • 41. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.
    Wang L; Panagiotoglou D; Min JE; DeBeck K; Milloy MJ; Kerr T; Hayashi K; Nosyk B
    Drug Alcohol Depend; 2016 Nov; 168():22-29. PubMed ID: 27610937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh.
    Rahman M; Janjua NZ; Shafiq TKI; Chowdhury EI; Sarker MS; Khan SI; Reza M; Faruque MO; Kabir A; Anis AH; Azim T
    Int J Drug Policy; 2019 Dec; 74():69-75. PubMed ID: 31542689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
    Mazhnaya A; Meteliuk A; Barnard T; Zelenev A; Filippovych S; Altice FL
    Int J Drug Policy; 2017 Sep; 47():187-195. PubMed ID: 28811159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
    Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
    Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs.
    Motavalli D; Taylor JL; Childs E; Valente PK; Salhaney P; Olson J; Biancarelli DL; Edeza A; Earlywine JJ; Marshall BDL; Drainoni ML; Mimiaga MJ; Biello KB; Bazzi AR
    J Gen Intern Med; 2021 Jan; 36(1):129-137. PubMed ID: 32918199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants.
    Folch C; Saludes V; Reyes-Ureña J; Antuori A; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2021 Apr; 90():103057. PubMed ID: 33310634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.
    Datta S; Horwood J; Hickman M; Sharp D
    Br J Gen Pract; 2014 Feb; 64(619):e67-74. PubMed ID: 24567619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
    Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs.
    Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS
    Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico.
    Carmody MD; Wagner K; Bizstray B; Thornton K; Fiuty P; Rosario AD; Teshale E; Page K
    Public Health Rep; 2023; 138(6):936-943. PubMed ID: 36633367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Access to HIV treatment and care for people who inject drugs in Kenya: a short report.
    Guise A; Rhodes T; Ndimbii J; Ayon S; Nnaji O
    AIDS Care; 2016 Dec; 28(12):1595-1599. PubMed ID: 27267309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
    Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M;
    BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
    Harris M; Albers E; Swan T
    Int J Drug Policy; 2015 Oct; 26(10):963-9. PubMed ID: 26143385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs.
    Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ
    Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health Network.
    Morris L; Smirnov A; Kvassay A; Leslie E; Kavanagh R; Alexander N; Davey G; Williams O; Gilks C; Najman J
    Int J Drug Policy; 2017 Sep; 47():216-220. PubMed ID: 28666635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs.
    Karasz A; Singh R; McKee MD; Merchant K; Kim AY; Page K; Pericot-Valverde I; Stein ES; Taylor LE; Wagner K; Litwin AH
    J Subst Abuse Treat; 2022 Sep; 140():108768. PubMed ID: 35729038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
    PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study.
    Kracht PAM; de Gee EA; van der Poel A; Verhagen MAMT; Hoepelman AIM; Croes EA; Arends JE
    Harm Reduct J; 2019 Jul; 16(1):45. PubMed ID: 31307470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.